Market Overview

UBS Maintains Neutral on Eli Lilly and Company, Raises PT to $51.00

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for LLY

DateFirmActionFromTo
Jul 2016JefferiesMaintainsBuy
May 2016Leerink SwannMaintainsOutperform
May 2016Credit SuisseMaintainsOutperform

View More Analyst Ratings for LLY
View the Latest Analyst Ratings

Posted-In: News Price Target Analyst Ratings

 

Related Articles (LLY)